ANXA1 and ANXA2 interact with DYSF to mediate sarcolemma repair [40] and both ANXA have been reported to be upregulated in Italian [129], American [130], or Australian patients [131] suffering from dysferlinopathies. Here, ANXA2 is linked to neuromuscular disease caused by qualitative or quantitative defects of dysferlin.